PWM
AZN icon

Paulson Wealth Management’s AstraZeneca AZN Stock Holding History

Paulson Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-558
Closed -$39K – 143
2017
Q4 		$39K Buy
+558
New +$37.6K 0.03% 217

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Paulson Wealth Management's AZN Position: Q1 2018 in Review

Paulson Wealth Management sold out of AstraZeneca (AZN) in Q1 2018, closing a stake of 558 shares — an estimated $39K sold.

Paulson Wealth Management first reported a position in AZN in Q4 2017 and held it in 1 quarter. The position peaked at $39K in Q4 2017. 519 funds tracked by Wall St. Rank hold AZN as of Q1 2018.

  • Paulson Wealth Management reported no remaining AstraZeneca position as of Q1 2018 after selling out during the quarter.
  • Paulson Wealth Management sold 558 AstraZeneca shares in Q1 2018, an estimated $39K.
  • Paulson Wealth Management first reported a position in AstraZeneca in Q4 2017 and held it in 1 quarter.
  • Paulson Wealth Management's AstraZeneca position peaked at $39K in Q4 2017.
  • 519 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2018.

Based on Paulson Wealth Management's 13F filing for Q1 2018, filed 2 May 2018.